ArchIntel

JUNE 2, 2021

pharmaceutical industry in 2021 and beyond. The race to create new products against COVID-19 amid the emergence of new mutations is expected to eclipse every other effort in health care and pharmaceuticals this year. pharmaceutical and health care industry’s more notable CI executives. ArchIntel™ -.

Pharmaceutical 104

Pharmaceutical Competitive Competitive Intelligence Profiling 104

ArchIntel

JANUARY 13, 2021

Executive Profile: Stefanie Kowitt, Capture Excellence and CI Team Lead at Lockheed Martin. Her current position also tasks Kowitt to ensure the timely delivery of actionable competitive intelligence analysis to in-house capture teams, according to her LinkedIn profile. Stefanie Kowitt CI Team Lead Lockheed Martin.

Competitive Intelligence 104

Competitive Intelligence Pharmaceutical Profiling Briefing 104

ArchIntel

APRIL 14, 2021

These are the profiles of some of those executives. Executive Profile: Christine Calderon, Marketing Manager at UPS. Executive Profile: Beth Kinzer, Global Director of Corporate Strategy at UPS. Prior to joining UPS, she spent four months at Celgene , a pharmaceutical company operating under Bristol Myers Squibb.

Competitive 104

Competitive Profiling Pharmaceutical Globalization 104

ArchIntel

APRIL 21, 2021

Interestingly, the pharmaceutical and medicine manufacturing subsector has seen the highest job growth numbers recently, even overtaking the aerospace products and parts subsector. Executive Profile: Anupama Pokharna, Senior Market and Competitive Intelligence Manager at Western Digital. As of 2019, there were some 12.8

Competitive Intelligence 104

Competitive Intelligence Profiling Competitive Pharmaceutical 104

ArchIntel

MARCH 17, 2021

These are the profiles of some of them. Executive Profile: Arnold DuBell, Associate Competitive and Strategic Intelligence Director at Novartis. Prior to working at Novartis, he spent 12 years at Kantar Health , a life sciences company headquartered in New York, according to his LinkedIn profile.

Pharmaceutical 104

Pharmaceutical Competitive Competitive Intelligence Profiling 104

Alpha Sense BI

NOVEMBER 9, 2022

Starting Oct 18, with Netflix’s earnings call, through November 10th with JOYY’s earnings, we’ll dynamically update this page with the relevant takeaways and respective earnings transcript snippets designed to give a briefing of the company’s earnings call. By segment: Pharmaceutical margins declined from 43.8% BP PLC [BP].

Sales 52

Sales Loss Capital Biotech 52